Refine by
Healthcare Market Articles & Analysis
84 news found
“Our team at Ace Therapeutics is committed to advancing the field of biotechnology to address emerging challenges in healthcare,” said the marketing manager of Ace Therapeutics. “With our vaccine development services, we are excited to offer a proactive approach to combatting superbugs and reducing the threat of antibiotic resistance. ...
“The CE Mark represents a major step forward in enhancing patient care and safety for endovascular therapies in the EU, a market with a higher prevalence of PE when compared to the United States,” said Laura Piccinini, AngioDynamics Senior Vice President/General Manager, Endovascular Therapies and International. “This designation allows us to broaden our reach ...
What is the opportunity for stocks in the sector? The AI in Healthcare market is projected to grow from USD 20.9 billion in 2024 and reach USD 148.4 billion by 2029. Prophecy Market Research says it could reach US$ 508.7 billion by 2034. From data to diagnostics and imaging, drug development and discovery, early intervention and predictive ...
Specifically, the Consortium’s purpose is to: Promote the adoption of the PERT model in healthcare institutions across the United States to ensure the prompt diagnosis and treatment of PE. ...
With this strategic engagement, the companies will combine their healthcare datasets and delivery resources to offer bundled software and services solutions to healthcare companies and insurance companies in these markets. ...
During and after the COVID-19 pandemic, a number of companies marketed their UV microbial reduction products as “disinfection” devices and many made unsubstantiated claims regarding the efficacy of their products. ...
Vizient serves approximately 97% of the nation's Academic Medical Centers, more than 50% of the nation's acute care health system, and serves more than 20% of the nation's ambulatory market. This contract enables TOMI to supply SteraMist systems to a wide range of healthcare providers, including academic medical centers, pediatric facilities, and community health ...
Medical probiotic leader Bened Biomedical Co., Ltd., which develops and markets neuroactive probiotic products, announced a completed Series A round of fundraising, receiving more than $10 million of capital from two prominent investors, Trans-Pacific Technology Fund (TPTF) and JAFCO Asia. With strategic support from these venture capital partners, Bened expects to rapidly expand its ...
Previously, she was Senior Vice President of Everly Health and held key leadership positions as Vice President of Commercial Operations & Sales for athenahealth and Vice President of Operations for Epocrates. A seasoned professional in healthcare marketing, finance and commercial partnerships, Gervais was instrumental in the athenahealth-Epocrates ...
“Japan is the second largest healthcare market in the world and represents a valuable opportunity to bring our innovative treatment to a large group of patients who have had few options once medical management alone fails to control their ...
Gillian has been published in the International Journal of Gynecology and Obstetrics, has presented at the Midwest Biomedical Engineering Career Conference and Appropriate Healthcare Technologies for Developing Countries Seminar in London, and was named Baltimore’s Technologist of the Year. ...
The top selling name brand product launched by the originator in 2007 independently sold over $375 million of its Rotigotine TDS patches in 2021. According to Wissen Market Research, total global sales for Rotigotine patches were approximately US$518 million in 2021 with the market expected to surpass US$766 million by 2030. XPhyto’s Rotigotine transdermal ...
(NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion at the American Medical Device Summit on October 19, 2022 in Chicago, Illinois. ...
According to Emergen Research, the global recurrent market for AFib is expected to reach USD$26 billion by 2027, growing at a CAGR of 13.2%. ...
-based multicenter clinical study for a computer aided polyp detection (CADe) device completed to date, which determined that SKOUT significantly improved overall adenoma detection in screening and surveillance colonoscopy compared to standard colonoscopy.1 In March 2021, Provation and Iterative Scopes entered a partnership focused on delivering artificial intelligence-based solutions to ...
(NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity’s innovative artificial intelligence-driven (‘AI’) system of real-time monitoring and prediction technology, in subjects with ...
NewGen Surgical’s mission is founded on offering sustainable solutions to eliminate single-use plastic in healthcare and is directly aligned with the USDA BioPreferred Program’s goals. ...
Following their success at Arab Health, Clear Surgical Ltd now has several opportunities lined up to translate the unrivalled opportunities OpLight™ presents for surgeons in the UK, over to the thriving Middle East healthcare market. Michelle Ward, Chairman and CEO at Clear Surgical Ltd, commented: “As a result of our week at Arab Health, we are now ...
Buechel, currently the Chief Operating Officer of Delfi Diagnostics, brings decades of life science experience developing and commercializing novel healthcare technologies from concept to market. Her proven success spans a spectrum of life science companies, including GRAIL and Guardant Health where she developed and executed successful product launch strategies, ...
“It will provide us with additional marketing research and customer feedback to aid our commercialization efforts, and it will support the process as we move toward FDA clearance for the Orchid ...